Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values

Abstract To define the features of glycemic variations in drug naïve type 2 diabetic (T2D) patients with different HbA1c values using continuous glucose monitoring (CGM), a total of 195 drug naïve T2D patients were admitted. The subjects were divided into the following groups: lower HbA1c values (≤8...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Feng-fei Li, Bing-li Liu, Reng-na Yan, Hong-hong Zhu, Pei-hua Zhou, Hui-qin Li, Xiao-fei Su, Jin-dan Wu, Dan-feng Zhang, Lei Ye, Jian-hua Ma
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b96179670feb4674a1e955376173cb4a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b96179670feb4674a1e955376173cb4a
record_format dspace
spelling oai:doaj.org-article:b96179670feb4674a1e955376173cb4a2021-12-02T12:31:49ZFeatures of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values10.1038/s41598-017-01719-y2045-2322https://doaj.org/article/b96179670feb4674a1e955376173cb4a2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01719-yhttps://doaj.org/toc/2045-2322Abstract To define the features of glycemic variations in drug naïve type 2 diabetic (T2D) patients with different HbA1c values using continuous glucose monitoring (CGM), a total of 195 drug naïve T2D patients were admitted. The subjects were divided into the following groups: lower HbA1c values (≤8%), moderate HbA1c values (>8% and ≤10%), and higher HbA1c values (>10%). The patients underwent oral glucose tolerance tests and were then subjected to 3-day CGM. The primary endpoint was the differences in the 24-hr mean amplitude of glycemic excursions (MAGE) in patients with different HbA1c values. Patients with higher HbA1c values had larger MAGEs than those in the moderate and lower groups (7.44 ± 3.00 vs. 6.30 ± 2.38, P < 0.05, 7.44 ± 3.00 vs. 5.20 ± 2.35, P < 0.01, respectively). The 24-hr mean glucose concentrations increased incrementally in the patients with lower, moderate and higher HbA1c values. Moreover, the patients with higher HbA1c values exhibited higher peak glucose concentrations and prolongation in the time to peak glucose. Patients with higher HbA1c values had larger MAGE compared with those with lower and moderate HbA1c values. Our data indicated patients with higher HbA1c values should receive special therapy aimed at reducing the larger glycemic variations.Feng-fei LiBing-li LiuReng-na YanHong-hong ZhuPei-hua ZhouHui-qin LiXiao-fei SuJin-dan WuDan-feng ZhangLei YeJian-hua MaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Feng-fei Li
Bing-li Liu
Reng-na Yan
Hong-hong Zhu
Pei-hua Zhou
Hui-qin Li
Xiao-fei Su
Jin-dan Wu
Dan-feng Zhang
Lei Ye
Jian-hua Ma
Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
description Abstract To define the features of glycemic variations in drug naïve type 2 diabetic (T2D) patients with different HbA1c values using continuous glucose monitoring (CGM), a total of 195 drug naïve T2D patients were admitted. The subjects were divided into the following groups: lower HbA1c values (≤8%), moderate HbA1c values (>8% and ≤10%), and higher HbA1c values (>10%). The patients underwent oral glucose tolerance tests and were then subjected to 3-day CGM. The primary endpoint was the differences in the 24-hr mean amplitude of glycemic excursions (MAGE) in patients with different HbA1c values. Patients with higher HbA1c values had larger MAGEs than those in the moderate and lower groups (7.44 ± 3.00 vs. 6.30 ± 2.38, P < 0.05, 7.44 ± 3.00 vs. 5.20 ± 2.35, P < 0.01, respectively). The 24-hr mean glucose concentrations increased incrementally in the patients with lower, moderate and higher HbA1c values. Moreover, the patients with higher HbA1c values exhibited higher peak glucose concentrations and prolongation in the time to peak glucose. Patients with higher HbA1c values had larger MAGE compared with those with lower and moderate HbA1c values. Our data indicated patients with higher HbA1c values should receive special therapy aimed at reducing the larger glycemic variations.
format article
author Feng-fei Li
Bing-li Liu
Reng-na Yan
Hong-hong Zhu
Pei-hua Zhou
Hui-qin Li
Xiao-fei Su
Jin-dan Wu
Dan-feng Zhang
Lei Ye
Jian-hua Ma
author_facet Feng-fei Li
Bing-li Liu
Reng-na Yan
Hong-hong Zhu
Pei-hua Zhou
Hui-qin Li
Xiao-fei Su
Jin-dan Wu
Dan-feng Zhang
Lei Ye
Jian-hua Ma
author_sort Feng-fei Li
title Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
title_short Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
title_full Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
title_fullStr Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
title_full_unstemmed Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
title_sort features of glycemic variations in drug naïve type 2 diabetic patients with different hba1c values
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/b96179670feb4674a1e955376173cb4a
work_keys_str_mv AT fengfeili featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT bingliliu featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT rengnayan featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT honghongzhu featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT peihuazhou featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT huiqinli featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT xiaofeisu featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT jindanwu featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT danfengzhang featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT leiye featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
AT jianhuama featuresofglycemicvariationsindrugnaivetype2diabeticpatientswithdifferenthba1cvalues
_version_ 1718394300976332800